Abstract

Allergic diseases pose significant challenges to patients and healthcare providers, necessitating effective and targeted therapeutic interventions. Cytokine-targeted biologics have emerged as a promising avenue in allergy management, offering precision therapy by selectively modulating key immune pathways involved in allergic inflammation. This abstract provides an overview of the mechanisms, clinical applications, and future prospects of cytokine-targeted biologics in allergy management. By targeting specific cytokines or their receptors, such as IgE or IL-4/IL-13, these biologics offer targeted intervention and symptom relief for patients with allergic rhinitis, asthma, atopic dermatitis, and other allergic conditions. With their potential to improve outcomes and quality of life for allergic patients, cytokine-targeted biologics represent a cornerstone in the era of precision medicine for allergic diseases.